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Foreword 
The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. 
We employ an empirical model, verified with the evolution of the number of confirmed cases in previous 
countries where the epidemic is close to conclude, including all provinces of China. The model does not 
pretend to interpret the causes of the evolution of the cases but to permit the evaluation of the quality of 
control measures made in each state and a short-term prediction of trends. Note, however, that the effects 
of the measures’ control that start on a given day are not observed until approximately 7-10 days later. 
 The model and predictions are based on two parameters that are daily fitted to available data: 
 a: the velocity at which spreading specific rate slows down; the higher the value, the better the 
control.  
 K: the final number of expected cumulated cases, which cannot be evaluated at the initial stages 
because growth is still exponential. 
We show an individual report with 8 graphs and a table with the short-term predictions for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. The predicted period of a country depends on 
the number of datapoints over this 100 cases threshold, and is of 5 days for those that have reported more 
than 100 cumulated cases for 10 consecutive days or more. For short-term predictions, we assign higher 
weight to last 3 points in the fittings, so that changes are rapidly captured by the model. The whole 
methodology employed in the inform is explained in the last pages of this document. 
In addition to the individual reports, the reader will find an initial dashboard with a brief analysis of the 
situation in EU-EFTA-UK countries, some summary figures and tables as well as long-term predictions for 
some of them, when possible. These long-term predictions are evaluated without different weights to data-
points. We also discuss a specific issue every day.  
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(0) Executive summary – Dashboard  
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Global EU+EFTA+UK trends and needs 
The situation in the USA may 
seem catastrophic, but before 
stating assessments it is good 
to compare it with other 
actors. USA is a huge state with 
about 407 million inhabitants. 
Therefore, it is comparable in 
size to EU+EFTA+UK, with 484 
million inhabitants. If we fit the 
Gompertz model to USA 
cumulative cases and to 
EU+EFTA+UK as a whole, we 
find that they are really 
comparable. In fact, the 
situation in Europe is probably 
worse in some aspects. In the 
USA, the model currently 
predicts a final picture of 
about 1.7 million infected and about 130,000 deaths. In Europe, predictions point to 1.4 million cases and 
about 180,000 deaths. The number of cases, even if we consider its ratio per population, is lower in Europe, 
but the death toll is not. If current trends are maintained, the USA they can reach 32 deaths per 100,000 
inhabitants and in Europe we would reach about 38 deaths per 100,000 inhabitants. These are the forecasts 
if we consider the Gompertz fitting, with an R2 of over 0.999 (except for US mortality, with an R2 of 0.996). 
The fitting excellent, but the deconfinement phase can slow down current trends and then the values could 
increase significantly.  
In the last section we analyse the timeline of the epidemic in Europe, looking at the particular dynamics in 
the countries.  
Trends for specific countries 
United Kingdom and Sweden present similar EPG (94 and 92 respectively), although there is one order of 
magnitude difference between absolute number of new cases (4,000 and 400-700, respectively). Cumulative 
incidence is higher in UK (329 per 105 inh.) than in Sweden (264 per 105 inh.), but their 14-day attack rates 
are closer (99 and 79 per 105 inhabitants, respectively). There are many countries with a ρ7 close to 1, but 
this is not necessarily worrying if it is not combined with a moderate or high number of active cases. 
Therefore, most EPGs are at the low risk level. High ρ7 of Portugal is probably related with some problems on 
reporting data. France still presents a ρ7 affected by the one-day peak of the last week. 
The maps are today included in the Analysis section.  
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Situation and trends per country 
Table of current situation in EU countries. Colour scale is relative except when indicated, this means that it is 
applied independently to each column, and distinguishes best (green) form worst (red) situations according 
to each of the variables. Last column (EPGEST) indicates EPG assessed with estimated real 14-day attack rate 
(see report from 22/04 for details). EPGREP is calculated with data reported by countries. EPGREP and EPGEST 
cannot be compared between them because scales are different, but can be independently used for 
estimating risk of countries according to reported or estimated real situation, respectively.    
 
(1) ρ3 is the average of 7 consecutive ρ, but can still fluctuate. (2) EPG stands for Effective Growth Potential. EPGREP is 
obtained by multiplying attack rate of last 14 days per 105 inhabitants (i.e. density of cases) by ρ7 (a value related with 
effective reproduction number and that, therefore, determines the dynamics for subsequent days). EPGEST is obtained 
by multiplying estimated real attack rate of last 14 days per 105 inhabitants by ρ7. 
 
Highlights for countries with highest number of reported cases 
 Spain is revising the historical series of Catalunya, one of the regions with highest incidence, whose 
data are behind the observed one-day peak.   
 UK could start a slow decreasing trend the next days, but this still has to be confirmed during this 
week.  




Analysis: Epidemic timeline at European level. 
The European onset of Covid19 local contagions was in Italy, last week of February. If we take the threshold 
of 100 cumulative cases to determine the onset, this value was reached on February 24. According to data 
reported by countries, France and Germany overcame the 100 cases on March 1, and Spain 2 days later. 
Belgium, Netherlands, Sweden, Norway, Switzerland and United Kingdom reached this level between 6 and 
7 March. Globally, temporal variation in the onset is relatively low (1 month), but subsequent evolution 
drastically varied from one country to another. In the next table, we show: 
- The days from onset, taking onset as the moment at which 100 cases were reached. 
- The time from a cumulative incidence of 1 case per 105 inhabitants to 10 cases per 105 inh. 
- The time from a cumulative incidence of 10 cases per 105 inhabitants to 100 cases per 105 inh. 
Colour scale indicate if first and second growth stages were rapid (red) or slow (green). As seen, there is a 
wide variety of velocities among countries. Iceland, Denmark, Estonia,  Slovenia and Luxembourg took 4-6 
days for the first time interval. Nevertheless, second stage was faster in Luxembourg (7 days), Spain (12), 
Switzerland (12), Austria (14), Belgium (14), Iceland (15) and Finland (15).  
 
The current situation is shown in the following maps. We show the current distribution of cumulative 
incidence, 14-day attack rate (A14), 7-day average spreading rate (ρ7) and EPG index. 
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Cumulative incidence per region  
(data from 12th May) 
A14 per region 
(data from 10th May) 
  
ρ7 
(data from 12th May) 
EPG per country 
(data from 12th May) 
  
 
A visual way to see the current situation is to locate countries in the risk diagram. The next figure shows 
the EU+EFTA+UK risk diagram together with the current situation of individual countries. Europe as a whole 
has reached intermediate-risk values since it comprises countries that have been in a worrying situation but 
also countries where Covid19 has not penetrated significantly. Currently, the UK, Sweden, Ireland, Portugal, 
and Belgium are at intermediate risk, still (yellow zones). The remaining countries are close to or already in 
the green zone.  
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The particular evolution of each country can be visualized through the risk dashboard that we introduced 
yesterday. In the following figure, we show a sample of a few countries. The whole risk dashboard can be 
found as an appendix file of this report.  
 
As explained yesterday with the example of Italian regions, a significant increase in ρ7 is immediately 
followed by EPG with a certain delay (e.g. Austria and Belgium). If EPG does not follow such increase (e.g. 
Bulgaria and Croatia), it is a clear symptom of low risk (i.e., an increase in spreading rate does not necessarily 
mean an increase in risk, as it depends on active cases to spread the disease at that rate).  
ρ7 A14 EPG ρ7 A14 EPG ρ7 A14 EPG ρ7 A14 EPG ρ7 A14 EPG ρ7 A14 EPG ρ7 A14 EPG ρ7 A14 EPG
09/03/2020 3.34 2 8 3.53 1 4 4.00 2 7 0.86 0 0 0.86 0 0 0.00 0 0 3.94 0 1 3.66 1 2
10/03/2020 3.30 3 10 3.50 1 5 4.00 2 8 1.43 0 0 0.71 0 0 0.29 0 0 3.94 0 1 3.80 2 7
11/03/2020 3.22 3 11 3.61 2 7 3.76 2 9 1.71 0 0 0.60 0 0 0.57 0 0 3.94 1 2 3.80 5 17
12/03/2020 3.19 4 14 3.59 3 10 3.36 3 9 2.14 0 0 0.81 0 0 1.14 0 1 3.94 1 3 3.94 9 35
13/03/2020 3.17 6 18 3.65 4 14 2.95 3 10 2.71 0 1 1.29 1 1 1.71 0 1 3.94 1 4 3.94 12 46
14/03/2020 3.13 7 22 3.65 6 20 2.65 5 13 3.29 0 1 1.79 1 1 2.29 1 3 3.94 1 6 3.94 14 55
15/03/2020 3.05 8 26 3.65 7 26 2.49 6 15 3.57 1 2 2.21 1 2 2.86 2 5 4.00 2 8 3.87 14 55
16/03/2020 2.95 10 30 3.65 9 34 2.49 8 19 3.57 1 3 2.71 1 3 3.43 2 9 4.00 3 11 3.47 15 52
17/03/2020 2.77 12 33 3.62 11 40 2.49 9 23 3.57 1 3 3.21 1 4 3.71 3 12 3.88 3 12 2.94 16 47
18/03/2020 2.64 14 36 3.52 15 51 2.65 11 28 3.59 1 4 3.49 1 5 4.00 3 13 3.72 4 15 2.42 18 42
19/03/2020 2.50 16 41 3.46 18 62 2.78 13 35 3.37 1 4 3.47 2 6 3.76 5 18 3.51 5 17 1.91 19 36
20/03/2020 2.40 20 48 3.40 24 81 2.89 15 44 2.98 2 5 3.23 2 7 3.36 5 16 3.36 6 21 1.44 20 28
21/03/2020 2.31 24 54 3.21 29 92 2.91 19 54 2.65 2 5 3.01 3 8 2.95 6 16 3.16 8 26 1.03 21 22
22/03/2020 2.24 27 61 3.02 32 98 2.86 23 65 2.40 2 6 3.01 5 14 2.52 7 18 2.93 9 27 0.78 22 17
23/03/2020 2.13 31 66 2.75 39 108 2.70 28 75 2.12 3 6 3.01 5 16 2.23 8 18 2.67 11 28 0.83 23 19
24/03/2020 2.06 35 71 2.58 48 125 2.48 30 75 1.80 3 5 3.01 7 22 1.91 9 18 2.43 11 27 0.91 23 21
25/03/2020 1.99 39 77 2.43 57 138 2.28 35 79 1.69 3 5 3.18 9 29 1.65 10 17 2.18 12 27 1.04 23 24
26/03/2020 1.93 43 83 2.33 63 146 2.21 40 88 1.65 3 6 3.38 10 33 1.52 10 16 1.96 15 29 1.18 21 25
27/03/2020 1.83 48 89 2.18 74 161 2.20 50 111 1.60 3 6 3.27 11 37 1.51 12 18 1.80 18 33 1.36 21 28
28/03/2020 1.74 54 94 2.04 80 163 2.17 58 126 1.49 4 6 3.14 14 42 1.50 12 18 1.70 20 34 1.46 21 31
29/03/2020 1.63 59 96 1.85 85 156 2.22 73 162 1.34 4 6 2.75 15 42 1.49 13 19 1.78 23 41 1.56 24 37
30/03/2020 1.53 62 96 1.66 88 146 2.25 86 194 1.26 4 5 2.36 16 38 1.45 15 22 1.75 24 41 1.66 26 44
31/03/2020 1.42 66 94 1.44 96 138 2.33 93 217 1.17 4 5 1.95 18 35 1.47 16 23 1.75 25 43 1.77 28 50
01/04/2020 1.36 70 96 1.28 98 125 2.25 100 223 1.13 5 5 1.58 19 31 1.54 18 28 1.70 27 46 1.82 32 58
02/04/2020 1.30 74 97 1.14 101 115 2.18 108 234 1.10 5 5 1.30 21 28 1.75 22 38 1.67 29 48 1.84 34 63
03/04/2020 1.25 77 96 0.97 99 96 2.03 117 237 1.13 5 6 1.21 22 27 1.97 25 49 1.54 30 46 1.80 39 69
04/04/2020 1.18 79 94 0.84 99 83 1.88 125 236 1.15 5 6 1.13 23 26 2.10 27 57 1.44 31 44 1.78 43 77
05/04/2020 1.12 81 91 0.73 97 71 1.62 135 218 1.16 5 6 1.06 22 24 2.19 28 62 1.18 32 38 1.71 47 81
06/04/2020 1.06 83 88 0.68 93 63 1.34 141 188 1.11 5 6 0.99 23 23 2.10 29 61 1.07 32 34 1.64 51 84
07/04/2020 1.02 83 85 0.62 87 54 1.09 147 161 1.06 5 5 0.92 22 20 1.93 29 56 0.97 33 33 1.60 56 89
08/04/2020 0.98 84 82 0.59 82 48 1.04 155 161 1.01 5 5 0.86 22 19 1.61 31 49 0.95 34 32 1.55 60 93
09/04/2020 0.95 84 80 0.59 79 46 1.02 159 163 0.97 5 5 0.79 23 18 1.30 33 42 0.95 34 32 1.49 63 95
10/04/2020 0.94 84 78 0.62 69 43 1.04 162 168 0.94 5 5 0.82 22 18 1.05 35 36 0.95 33 31 1.39 65 90
11/04/2020 0.93 83 77 0.67 65 44 1.06 167 178 0.91 5 4 0.86 22 19 0.93 36 33 0.92 32 30 1.25 65 81
12/04/2020 0.92 82 76 0.75 61 46 1.09 163 177 0.88 5 4 0.94 21 20 0.89 36 32 0.88 30 27 1.08 66 71
13/04/2020 0.93 81 75 0.80 57 45 1.09 162 178 0.83 5 4 1.00 22 22 0.88 35 31 0.83 30 25 0.94 65 62
14/04/2020 0.93 80 74 0.81 49 40 1.06 161 171 0.82 5 4 1.05 21 22 0.91 36 32 0.78 29 22 0.83 65 53
15/04/2020 0.93 78 72 0.79 45 36 1.01 158 160 0.81 5 4 1.08 20 22 0.94 36 34 0.73 26 19 0.73 63 46
16/04/2020 0.92 76 70 0.75 41 31 1.00 169 170 0.89 5 4 1.07 19 20 0.97 33 32 0.68 25 17 0.66 62 41
17/04/2020 0.90 74 67 0.69 37 26 1.00 168 168 1.00 5 5 1.01 19 19 0.96 31 30 0.65 24 16 0.66 60 40
18/04/2020 0.88 72 63 0.61 34 21 1.01 167 168 1.26 5 7 0.92 18 16 0.88 28 25 0.65 22 14 0.70 57 40
19/04/2020 0.86 70 60 0.55 32 18 0.98 162 158 1.48 5 8 0.81 17 14 0.79 28 22 0.67 20 14 0.76 55 42
20/04/2020 0.84 68 58 0.52 30 16 0.97 162 157 1.70 6 9 0.70 17 12 0.70 27 19 0.77 21 16 0.83 52 43
21/04/2020 0.84 67 56 0.51 28 14 0.96 165 158 1.75 5 10 0.63 16 10 0.65 25 17 0.87 20 17 0.88 49 43
22/04/2020 0.84 66 55 0.51 24 12 0.98 162 158 1.77 6 10 0.58 15 9 0.58 24 14 0.97 19 18 0.92 45 42
23/04/2020 0.86 63 54 0.52 22 11 0.95 160 152 1.71 6 11 0.59 15 9 0.55 22 12 1.03 17 18 0.96 43 42
24/04/2020 0.86 61 53 0.55 19 11 0.93 154 143 1.65 7 11 0.64 14 9 0.50 19 10 1.05 15 16 0.97 42 41
25/04/2020 0.88 59 52 0.60 17 10 0.91 152 138 1.54 8 12 0.74 13 9 0.51 17 9 1.01 14 14 0.96 41 40
26/04/2020 0.88 57 50 0.68 15 10 0.90 149 135 1.55 8 13 0.79 12 9 0.49 16 8 0.94 14 13 0.97 42 41
27/04/2020 0.87 55 48 0.77 14 11 0.86 142 122 1.53 9 14 0.82 10 9 0.57 15 9 0.81 13 11 0.99 41 41
28/04/2020 0.85 53 46 0.83 13 11 0.82 139 114 1.60 10 16 0.80 9 8 0.61 13 8 0.71 13 9 1.00 41 41
29/04/2020 0.84 51 43 0.90 12 11 0.79 140 111 1.61 10 16 0.77 8 6 0.74 12 9 0.64 13 8 0.99 40 40
30/04/2020 0.82 49 41 0.92 11 10 0.77 123 95 1.59 10 16 0.71 8 6 0.84 11 9 0.63 12 7 0.97 40 39
01/05/2020 0.81 47 38 0.94 11 10 0.74 118 87 1.50 10 15 0.64 7 4 0.97 10 9 0.67 12 8 0.96 39 38
02/05/2020 0.80 46 37 0.91 9 9 0.68 111 76 1.36 11 15 0.57 7 4 1.01 10 10 0.73 11 8 0.94 39 36
03/05/2020 0.80 44 35 0.83 9 7 0.65 106 69 1.10 10 11 0.55 6 3 1.10 9 9 0.79 10 8 0.89 37 33
04/05/2020 0.81 42 34 0.75 9 7 0.62 98 61 0.91 10 9 0.55 5 3 1.08 9 9 0.80 9 7 0.86 37 32
05/05/2020 0.80 41 33 0.71 9 6 0.62 89 55 0.74 10 8 0.57 5 3 1.06 8 9 0.80 8 7 0.84 37 31
06/05/2020 0.81 39 32 0.68 8 6 0.60 82 49 0.71 10 7 0.62 5 3 0.96 8 8 0.81 8 6 0.87 37 32
07/05/2020 0.84 39 32 0.69 8 6 0.60 77 46 0.73 11 8 0.66 4 3 0.86 8 7 0.82 8 6 0.89 36 32
08/05/2020 0.87 37 33 0.71 8 5 0.62 74 46 0.81 11 9 0.71 4 2 0.76 8 6 0.83 8 7 0.91 35 32
09/05/2020 0.91 36 33 0.80 7 6 0.70 67 47 0.96 10 10 0.95 4 4 0.71 7 5 0.94 8 7 0.94 35 33
10/05/2020 0.94 34 32 0.88 7 6 0.82 63 51 1.23 10 13 1.33 4 5 0.62 7 4 1.01 7 7 0.96 32 31
11/05/2020 0.95 34 32 0.93 7 6 0.96 60 57 1.33 10 13 1.61 4 6 0.60 7 4 1.01 7 7 0.95 32 30
12/05/2020 0.95 33 31 1.02 7 7 1.09 58 64 1.34 9 12 1.76 4 7 0.63 7 4 1.02 7 7 0.92 31 29
Czech Republic DenmarkEU+EFTA+UK Austria Belgium Bulgaria Croatia Cyprus
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Long-term predictions 
Long-term predictions, evaluated with the whole historical series and without weighting last 3 points. Up-
left: Predictions of maximum incidences per country (total final expected attack rate per 105 inh.). Up-right: 
Predictions of maximum absolute number of cases per country (K, in log scale). Blue lines indicate current 
situation. Bottom-left: Time in which peak in new cases was achieved / will be achieved. Bottom-right: Time 
at which 90 % of K was achieved / will be achieved. Blue dotted line indicates current date.  
 
Final expected K for UE+EFTA+UK. Evolution of 
predicted K with time, where convergence to best 
estimate is seen. Last prediction is numerically 


























(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2) EPG stands for Effective Growth Potential. EPGREP is 
obtained by multiplying attack rate of last 14 days per 105 inhabitants (i.e. density of cases) by ρ7 (a value related with 
effective reproduction number and that, therefore, determines the dynamics for subsequent days). EPGEST is obtained 






Legend: Countries’ reports details 
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Data obtained from  https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
 































































Data obtained from https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
 
(2) Analysis and prediction of COVID-19 

















































Data obtained from https://github.com/datadista/datasets/tree/master/COVID%2019 and 
https://covid19.isciii.es/  
 
(3) Analysis and prediction of COVID-19 


























































 Data obtained from: https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale  
 
(4) Analysis and prediction of COVID-19 





















































(1) Data source 
Data are daily obtained from World Health Organization (WHO) surveillance reports1, from European Centre 
for Disease Prevention and Control (ECDC)2 and from Ministerio de Sanidad3. These reports are converted 
into text files that can be processed for subsequent analysis. Daily data comprise, among others: total 
confirmed cases, total confirmed new cases, total deaths, total new deaths. It must be considered that the 
report is always providing data from previous day. In the document we use the date at which the datapoint 
is assumed to belong, i.e., report from 15/03/2020 is giving data from 14/03/2020, the latter being used in 
the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for EU individual countries and for the UE as a whole: 
 Number of cumulated confirmed cases, in blue dots 
 Number of reported new cases 
 Number of cumulated deaths  
Then, two indicators are calculated and plotted, too: 
 Number of cumulated deaths divided by the number of cumulated confirmed cases, and reported as 
a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑡𝑡 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t.  
(3) Classification of countries according to their status in the epidemic cycle 
The evolution of confirmed cases shows a biphasic behaviour:  
(I) an initial period where most of the cases are imported; 
(II) a subsequent period where most of new cases occur because of local transmission.  
Once in the stage II, mathematical models can be used to track evolutions and predict tendencies. Focusing 
on countries that are on stage II, we classify them in three groups: 
• Group A: countries that have reported more than 100 cumulated cases for 10 consecutive days or 
more; 
• Group B: countries that have reported more than 100 cumulated cases for 7 to 9 consecutive days; 
• Group C: countries that have reported more than 100 cumulated cases for 4 to 6 days. 
 




https://github.com/datadista/datasets/tree/master/COVID%2019 , https://covid19.isciii.es/ 
111
(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model4 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic that is characterized by an initial 
exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied.   
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulated cases of the UE and of countries in stage II that accomplish two 
criteria: 4 or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 
200 cases. Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that 
accomplish the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s 
Curve Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of 
fitted parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K 
cannot be correctly evaluated. In fact, at this stage the most relevant parameter is a. Fitted curves are 
incorporated to plots of cumulative reported cases with a dashed line. Once a new fitting is done, two plots 
are added to the country report: 
 Evolution of fitted a with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out;  
 Evolution of fitted K with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out; if lower error bar indicates a value that is lower than current number of cases, 
the error bar is truncated. 
These plots illustrate the increase in fittings’ confidence, as fitted values progressively stabilize around a 
certain value and error bars get smaller when the number of datapoints increases. In fact, in the case of 
countries, they are discarded and set as “Not enough data” if a>0.2 day-1, if K>106 or if the error in K 
overpasses 106. 
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases. The 
predictions increase their reliability with the number of datapoints used in the fitting. Therefore, we consider 
three levels of prediction, depending on the country: 
                                                          
4 Madden LV. Quantification of disease progression. Protection Ecology 1980; 2: 159-176. 
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• Group A: prediction of expected cumulated cases for the following 3-5 days5; 
• Group B: prediction of expected cumulated cases for the following 2 days; 
• Group C: prediction of expected cumulated cases for the following day. 
The confidence interval of predictions is assessed with the Matlab function predint, with a 99% confidence 
level. These predictions are shown in the plots as red dots with corresponding error bars, and also gathered 
in the attached table. For series longer than 9 timepoints, last 3 points are weighted in the fitting so that 
changes in tendencies are well captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors6 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
 
                                                          
5 At this moment we are testing predictions at 4 days for countries with more than 100 cumulated cases for 13-15 
consecutive days, and 5 days for 16 or more days.  
6 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 
cohort study. The Lancet; March 9, doi: 10.1016/S0140-6736(20)30566-3 
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